Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status

Publisher's Note

Richard Cote should have been listed as corresponding author instead of Walter Stadler, as follows:

Corresponding author: Richard J. Cote, MD, FRCPath, FCAP, Department of Pathology, University of Miami Miller School of Medicine, 1120 NW 14 St, Suite 1416, Miami, FL 33136; e-mail: rcote@med.miami.edu.

This has been corrected as of August 15, 2011. The authors apologize to the readers for the mistake.